Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
Denali Therapeutics(DNLI) stock is priced at $21.22, giving the company a market capitalization of 3.36B. It carries a P/E multiple of -6.63.
As of 2026-03-09, Denali Therapeutics(DNLI) stock has fluctuated between $19.96 and $21.48. The current price stands at $21.22, placing the stock +6.3% above today's low and -1.2% off the high.
Denali Therapeutics(DNLI) shares are trading with a volume of 1.21M, against a daily average of 1.44M.
In the last year, Denali Therapeutics(DNLI) shares hit a 52-week high of $23.77 and a 52-week low of $10.57.
In the last year, Denali Therapeutics(DNLI) shares hit a 52-week high of $23.77 and a 52-week low of $10.57.
DNLI News
Denali Therapeutics Inc. recently reported fourth-quarter and full-year 2025 results, with net losses of US$128.55 million for the quarter and US$512.54 million...
Analyst ratings
94%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.